Hospital
Woodlawn Hospital
Woodlawn Hospital was paid $5.30M by Medicaid between Jan 2018 and Nov 2024, across 93 billing codes. Its largest line is 99283, emergency room visit (moderate) — 36% of everything it billed.
33Billing provider infoWOODLAWN HOSPITAL
ROCHESTER, IN 46975
ROCHESTER, IN 46975
33aNPI1265413405assigned 11/07/2005
33bProvider typeCritical Access Hospital
28Total paid$5.30M
24GClaims110,774
24DCodes billed93
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Critical Access Hospital providers in Indiana
Rank by total paid#9 of 26
Median peer was paid$4.16M
This provider vs. median1.3×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 15,853 | $601K | |
| 2019 | 16,710 | $830K | |
| 2020 | 11,197 | $606K | |
| 2021 | 13,763 | $668K | |
| 2022 | 20,878 | $1.01M | |
| 2023 | 21,181 | $1.01M | |
| 2024incomplete | 11,192 | $579K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 36% | 14,696 | 11,531 | $1.91M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 14% | 8,916 | 7,139 | $753K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 13% | 6,750 | 4,727 | $663K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 8.3% | 3,125 | 2,555 | $440K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 5.2% | 5,788 | 4,371 | $275K |
| 71045 | Radiologic examination, chest; single view | 3.8% | 1,586 | 1,263 | $204K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 3.5% | 1,803 | 1,553 | $186K |
| 80053 | Comprehensive metabolic panel | 1.8% | 14,612 | 12,001 | $94K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.4% | 705 | 631 | $73K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 1.3% | 663 | 593 | $69K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.1% | 11,766 | 9,598 | $60K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 1.1% | 381 | 331 | $59K |
81 more codes
| 99214 | Doctor's office visit, returning patient (more involved) | 1.0% | 1,556 | $53K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 137 | $48K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 651 | $39K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 1,089 | $31K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 2,452 | $30K |
| 36415 | Collection of venous blood by venipuncture | <1% | 11,566 | $28K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 226 | $26K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 1,562 | $24K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 716 | $16K |
| 85027 | <1% | 2,541 | $13K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 166 | $12K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 494 | $12K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 96 | $11K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 480 | $11K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 95 | $11K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 166 | $10K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 245 | $10K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 109 | $10K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 56 | $9K |
| 11719 | <1% | 771 | $9K | |
| 80061 | Lipid panel | <1% | 1,186 | $9K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 40 | $7K |
| 81001 | <1% | 3,028 | $6K | |
| 83735 | <1% | 847 | $6K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 47 | $5K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,035 | $5K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 868 | $5K |
| 83615 | <1% | 216 | $5K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 97 | $4K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 180 | $4K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 97 | $4K |
| 84145 | <1% | 257 | $3K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 195 | $3K |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 334 | $3K |
| 20610 | <1% | 19 | $3K | |
| 87088 | <1% | 453 | $3K | |
| 84439 | <1% | 423 | $3K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 130 | $3K |
| 84484 | <1% | 172 | $2K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 26 | $2K |
| 83690 | <1% | 487 | $2K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 13 | $2K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 127 | $2K |
| 87631 | <1% | 25 | $2K | |
| 83605 | <1% | 228 | $1K | |
| 82607 | <1% | 143 | $1K | |
| 81003 | <1% | 783 | $1K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 34 | $1K |
| 80306 | <1% | 116 | $1K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 66 | $918.14 |
| 86140 | <1% | 237 | $796.45 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 59 | $778.69 |
| 82150 | <1% | 169 | $724.84 | |
| 36416 | <1% | 86 | $669.26 | |
| 81015 | <1% | 147 | $559.07 | |
| 73560 | <1% | 15 | $528.50 | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 49 | $528.04 |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 100 | $506.19 |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 17 | $354.96 |
| 82550 | <1% | 66 | $300.88 | |
| 84481 | <1% | 28 | $266.74 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 117 | $244.80 |
| 85018 | <1% | 60 | $124.77 | |
| 82746 | <1% | 13 | $117.60 | |
| 87040 | <1% | 19 | $104.96 | |
| 85610 | <1% | 26 | $96.05 | |
| 90686 | <1% | 195 | $91.34 | |
| 82947 | <1% | 26 | $77.42 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 17 | $74.57 |
| 84703 | <1% | 12 | $69.94 | |
| 85730 | <1% | 16 | $45.92 | |
| 82553 | <1% | 18 | $32.77 | |
| 81025 | <1% | 16 | $25.05 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 0% | 907 | $0.00 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 122 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 0% | 105 | $0.00 |
| J8540 | Dexamethasone, oral, 0.25 mg | 0% | 17 | $0.00 |
| J1170 | Injection, hydromorphone, up to 4 mg | 0% | 16 | $0.00 |
| J1040 | Injection, methylprednisolone acetate, 80 mg | 0% | 18 | $0.00 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 0% | 429 | $0.00 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBOWERS, CARRIE (CFO)
| Provider | Location | Paid |
|---|---|---|
| Woodlawn Hospital | Rochester, IN | $2.47M |
| Woodlawn Hospital | Rochester, IN | $1.34M |
| Woodlawn Hospital | Fulton, IN | $213K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.